BTI
AZN icon

Blue Trust Inc’s AstraZeneca AZN Stock Holding History

Blue Trust Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
17,511
+3,408
+24% +$641K 0.03% 142
2026
Q1 		$2.78M Buy
14,103
+5,106
+57% +$985K 0.03% 150
2025
Q4 		$1.65M Sell
8,997
-568
-6% -$99.6K 0.02% 214
2025
Q3 		$1.47M Buy
9,565
+329
+4% +$49.8K 0.02% 222
2025
Q2 		$1.29M Sell
9,236
-1,474
-14% -$207K 0.02% 226
2025
Q1 		$1.57M Buy
10,710
+826
+8% +$120K 0.02% 189
2024
Q4 		$1.3M Sell
9,884
-129
-1% -$18.1K 0.02% 204
2024
Q3 		$1.56M Buy
10,013
+5,827
+139% +$941K 0.02% 193
2024
Q2 		$567K Buy
4,186
+2,987
+249% +$449K 0.01% 337
2024
Q1 		$162K Sell
1,199
-732
-38% -$96.9K ﹤0.01% 574
2023
Q4 		$262K Sell
1,931
-354
-15% -$46K ﹤0.01% 369
2023
Q3 		$327K Buy
2,285
+823
+56% +$112K 0.01% 324
2023
Q2 		$203K Sell
1,462
-1,220
-45% -$180K ﹤0.01% 361
2023
Q1 		$363K Buy
2,682
+71
+3% +$9.55K 0.01% 362
2022
Q4 		$286K Buy
2,611
+1,455
+126% +$182K 0.01% 363
2022
Q3 		$153K Buy
1,156
+78
+7% +$9.89K ﹤0.01% 395
2022
Q2 		$143K Buy
+1,078
New +$141K ﹤0.01% 396

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Blue Trust Inc's AZN Position: Q2 2026 in Review

Blue Trust Inc increased its AstraZeneca (AZN) stake by 24% in Q2 2026, buying an estimated $641K and bringing the position to 17,511 shares worth $3.32M. The position accounts for 0.03% of the portfolio, ranked #142.

Blue Trust Inc first reported a position in AZN in Q2 2022 and has held it in 17 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Blue Trust Inc held 17,511 shares of AstraZeneca worth $3.32M as of Q2 2026.
  • Blue Trust Inc bought 3,408 AstraZeneca shares in Q2 2026, an estimated $641K.
  • AstraZeneca made up 0.03% of Blue Trust Inc's portfolio in Q2 2026, its #142 holding.
  • Blue Trust Inc first reported a position in AstraZeneca in Q2 2022 and has held it in 17 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.